Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,868 | -78,058 | -68,255 | -43,593 | -21,442 |
| Depreciation Amortization | 2,105 | -2,422 | -5,007 | 290 | 590 |
| Accounts receivable | 952 | 1,194 | -2,451 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,054 | -1,106 | -84 | 721 | 695 |
| Other Working Capital | -22,094 | -59,668 | -26,429 | 69,487 | 46,255 |
| Other Operating Activity | 16,959 | 30,987 | 10,817 | 2,819 | -1,841 |
| Operating Cash Flow | $-88,892 | $-109,073 | $-91,409 | $29,724 | $24,257 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -537 | -3,114 | -9,814 | -13,977 | -2,903 |
| Purchase Of Investment | -66,408 | -306,096 | -208,096 | -214,850 | -69,258 |
| Sale Of Investment | 170,474 | 221,053 | 263,644 | 106,627 | -2,155 |
| Investing Cash Flow | $103,529 | $-88,157 | $45,734 | $-122,200 | $-74,316 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 29,974 |
| Common Stock Issued | 202 | 84,013 | N/A | N/A | N/A |
| Other Financing Activity | -558 | 0 | 1,012 | 239,594 | 9,948 |
| Financing Cash Flow | $-356 | $84,013 | $1,012 | $239,594 | $39,922 |
| Beginning Cash Position | 32,634 | 145,851 | 190,514 | 43,396 | 53,533 |
| End Cash Position | 46,915 | 32,634 | 145,851 | 190,514 | 43,396 |
| Net Cash Flow | $14,281 | $-113,217 | $-44,663 | $147,118 | $-10,137 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,892 | -109,073 | -91,409 | 29,724 | 24,257 |
| Capital Expenditure | -574 | -3,114 | -9,814 | -13,977 | -2,903 |
| Free Cash Flow | -89,466 | -112,187 | -101,223 | 15,747 | 21,354 |